3.53
price up icon10.31%   0.33
 
loading
전일 마감가:
$3.20
열려 있는:
$3.24
하루 거래량:
237.38K
Relative Volume:
1.16
시가총액:
$6.82M
수익:
$895.50K
순이익/손실:
$-26.30M
주가수익비율:
-2.1524
EPS:
-1.64
순현금흐름:
$-23.84M
1주 성능:
+9.63%
1개월 성능:
-16.94%
6개월 성능:
-65.93%
1년 성능:
-89.70%
1일 변동 폭
Value
$3.14
$3.58
1주일 범위
Value
$3.03
$3.58
52주 변동 폭
Value
$2.65
$40.40

Mainz Biomed N V Stock (MYNZ) Company Profile

Name
명칭
Mainz Biomed N V
Name
전화
-
Name
주소
-
Name
직원
26
Name
트위터
Name
다음 수익 날짜
2025-04-28
Name
최신 SEC 제출 서류
Name
MYNZ's Discussions on Twitter

MYNZ을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Diagnostics & Research icon
MYNZ
Mainz Biomed N V
3.53 6.82M 895.50K -26.30M -23.84M -1.64
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
424.24 159.25B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
197.14 132.37B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
437.44 32.95B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
A
Agilent Technologies Inc
106.28 28.58B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
150.28 24.90B 15.41B 1.37B 2.11B 7.50

Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-14 개시 Maxim Group Buy
2024-11-25 다운그레이드 H.C. Wainwright Buy → Neutral
2023-11-21 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2022-06-21 개시 H.C. Wainwright Buy

Mainz Biomed N V 주식(MYNZ)의 최신 뉴스

pulisher
Apr 23, 2025

Long Term Trading Analysis for (MYNZ) - news.stocktradersdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

Mainz Biomed (NASDAQ:MYNZ) Trading Up 3.9% – What’s Next? - Defense World

Apr 23, 2025
pulisher
Apr 22, 2025

Colorectal to Pancreatic: Mainz Biomed Expands Reach in Early Cancer Detection - Markets Herald

Apr 22, 2025
pulisher
Apr 19, 2025

Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update - ADVFN

Apr 19, 2025
pulisher
Apr 07, 2025

(MYNZ) Investment Report - news.stocktradersdaily.com

Apr 07, 2025
pulisher
Apr 02, 2025

Mainz BioMed's Trial To Bring Critical Early Cancer Detection One Step Closer - Benzinga

Apr 02, 2025
pulisher
Apr 01, 2025

Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Mainz Biomed Reports 2024 Financial Success and Strategic Advances - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update - GlobeNewswire Inc.

Apr 01, 2025
pulisher
Apr 01, 2025

Virtu Financial LLC Takes $79,000 Position in Mainz Biomed (NASDAQ:MYNZ) - Defense World

Apr 01, 2025
pulisher
Apr 01, 2025

Mainz Biomed (MYNZ) Expected to Announce Quarterly Earnings on Tuesday - Defense World

Apr 01, 2025
pulisher
Mar 28, 2025

Mainz Biomed begins pivotal colorectal cancer test study By Investing.com - Investing.com Canada

Mar 28, 2025
pulisher
Mar 27, 2025

Mainz Biomed Enrolls First Patient In EAArly DETECT 2 Study To Advance Colorectal Cancer Test - Nasdaq

Mar 27, 2025
pulisher
Mar 27, 2025

Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study - The Manila Times

Mar 27, 2025
pulisher
Mar 27, 2025

Mainz Biomed begins pivotal colorectal cancer test study - Investing.com

Mar 27, 2025
pulisher
Mar 27, 2025

Revolutionary AI-Powered Cancer Test: Mainz Biomed Begins Major Clinical Trial - Stock Titan

Mar 27, 2025
pulisher
Mar 17, 2025

(MYNZ) Proactive Strategies - Stock Traders Daily

Mar 17, 2025
pulisher
Mar 13, 2025

Mainz Biomed secures license for pancreatic cancer test By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Mainz Biomed Licenses MRNA Biomarkers For Non-Invasive Pancreatic Cancer Screening Test - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Mainz Biomed, Liquid Biosciences Partner on Blood-Based Test for Pancreatic Cancer - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

Mainz Biomed’s Breakthrough in Pancreatic Cancer Detection - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

Mainz Biomed secures license for pancreatic cancer test - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer - The Manila Times

Mar 13, 2025
pulisher
Mar 13, 2025

Mainz Biomed Signs Exclusive Licensing Agreement with Liquid Biosciences for Novel mRNA Biomarkers in Pancreatic Cancer Detection - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Mainz Biomed and Liquid Biosciences Make Groundbreaking - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood ... - The Bakersfield Californian

Mar 13, 2025
pulisher
Mar 07, 2025

Mainz Biomed Vs. Aurinia Pharma: Retail Traders Weigh In On The Better Biotech Bet - MSN

Mar 07, 2025
pulisher
Mar 03, 2025

Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention - GlobeNewswire

Mar 03, 2025
pulisher
Mar 03, 2025

Can Mainz Biomed's 82% Detection Rate Technology Revolutionize Colorectal Cancer Prevention? - StockTitan

Mar 03, 2025
pulisher
Feb 24, 2025

(MYNZ) Trading Advice - Stock Traders Daily

Feb 24, 2025
pulisher
Feb 20, 2025

Mainz Biomed Expands into Switzerland with labor team w - GlobeNewswire

Feb 20, 2025
pulisher
Feb 20, 2025

Mainz Biomed Partners with labor team w ag to Launch ColoAlert® Colorectal Cancer Screening Test in Switzerland - Nasdaq

Feb 20, 2025
pulisher
Feb 20, 2025

First DNA-Based Cancer Test Enters Swiss Market: Can Mainz Biomed Transform Screening? - StockTitan

Feb 20, 2025
pulisher
Feb 16, 2025

Mainz Biomed (NASDAQ:MYNZ) Coverage Initiated at Maxim Group - Defense World

Feb 16, 2025
pulisher
Feb 14, 2025

Maxim Group Initiates Coverage of Mainz Biomed N.V. (MYNZ) with Buy Recommendation - Nasdaq

Feb 14, 2025
pulisher
Feb 13, 2025

How To Trade (MYNZ) - Stock Traders Daily

Feb 13, 2025
pulisher
Feb 11, 2025

Mainz Biomed and GANZIMMUN Announce Launch of Enhanced - GlobeNewswire

Feb 11, 2025
pulisher
Feb 11, 2025

Mainz Biomed Collaborates with GANZIMMUN Diagnostics to Launch Enhanced ColoAlert Colorectal Cancer Screening Test in Germany - Nasdaq

Feb 11, 2025
pulisher
Feb 11, 2025

Mainz Biomed's Revolutionary DNA Tech Powers New German Cancer ScreeningWhat Sets It Apart - StockTitan

Feb 11, 2025
pulisher
Feb 06, 2025

A stock that deserves closer examination: Mainz Biomed N.V (MYNZ) - US Post News

Feb 06, 2025
pulisher
Feb 04, 2025

The Future of Mainz Biomed N.V: Analyzing MYNZ - The InvestChronicle

Feb 04, 2025
pulisher
Jan 28, 2025

Mainz Biomed regains Nasdaq compliance with equity rule By Investing.com - Investing.com Canada

Jan 28, 2025
pulisher
Jan 27, 2025

Mainz Biomed regains Nasdaq compliance with equity rule - MSN

Jan 27, 2025
pulisher
Jan 27, 2025

Mainz Biomed Regains Nasdaq Listing Compliance - TipRanks

Jan 27, 2025
pulisher
Jan 27, 2025

Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements - GlobeNewswire

Jan 27, 2025
pulisher
Jan 27, 2025

Mainz Biomed Achieves Full Nasdaq Compliance, Secures Market Position - StockTitan

Jan 27, 2025
pulisher
Jan 24, 2025

Mainz Biomed (MYNZ) Stock Price, News & Analysis - MarketBeat

Jan 24, 2025

Mainz Biomed N V (MYNZ) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
diagnostics_research LH
$228.31
price down icon 0.12%
diagnostics_research DGX
$173.76
price down icon 1.20%
$153.79
price down icon 0.45%
diagnostics_research WAT
$337.89
price down icon 0.82%
diagnostics_research MTD
$1,061.79
price down icon 1.23%
diagnostics_research IQV
$150.28
price down icon 0.27%
자본화:     |  볼륨(24시간):